Delivery Order SPE2DR25D3501-SPE2DR26FL9VK
- Not listed
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This competitive, firm fixed-price delivery order carries a ceiling value of $8,528.34 and is due for completion by August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,585.02 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of June 18, 2025. The contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $53,925.36 on December 2, 2025, for the supply of VYVGART 400 MG/20 ML vials. This competitive, non-set-aside delivery order is structured as a firm fixed price contract with an ultimate completion date of December 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $42,641.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyvgart 400 mg/20 mL vials. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by June 24, 2025, with performance to be fulfilled at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $34,113.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This contract, with an ultimate completion date of October 14, 2025, represents a competitive, non-set-aside award to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $44,937.80 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of VYVGART 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 29, 2025, and performance to be executed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $34,113.36 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of VYVGART 400 mg/20 mL vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials on October 28, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialty pharmaceutical product used in the treatment of autoimmune...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9VKDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $8,987.56 on December 3, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This competitively awarded, firm fixed-price contract is scheduled for completion by December 24, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified suppliers. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply to military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this comprehensive vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 12/2/25 |